Revolution Medicines, Inc. (NASDAQ:RVMDW) Shares Shorted: Short Interest Down 64.8% in September

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the recipient of a significant drop in short interest in the month of September. As of September 15th, there was short interest totaling 703 shares, a drop of 64.8% from the August 31st total of 2,000 shares. Based on an average daily volume of 25,844 shares, the short-interest ratio is presently 0.0 days.

Revolution Medicines Price Performance

Shares of Revolution Medicines stock traded down $0.51 during midday trading on Monday, hitting $11.12. 6,894 shares of the company were exchanged, compared to its average volume of 104,593. The firm has a 50 day simple moving average of $10.85 and a 200-day simple moving average of $7.27. Revolution Medicines has a 52 week low of $0.23 and a 52 week high of $13.44.

About Revolution Medicines

Revolution Medicines, Inc is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer. The company specializes in medicines designed to inhibit mutated RAS proteins, including KRAS, which are important drivers of many solid tumors and have historically been difficult to target with drugs.

Its research and development pipeline includes RAS(ON) inhibitors intended to block active forms of RAS signaling. Key investigational programs have included pan-RAS inhibitors and mutation-selective candidates directed at alterations such as KRAS G12C and KRAS G12D.